Physiosol is a Irrigation Irrigant in the Human Prescription Drug category. It is labeled and distributed by Hospira, Inc.. The primary component is Sodium Chloride; Sodium Acetate Anhydrous; Sodium Gluconate; Potassium Chloride; Magnesium Chloride.
Product ID | 0409-6141_f9023ddc-a430-47a3-a7a9-ede847e8b974 |
NDC | 0409-6141 |
Product Type | Human Prescription Drug |
Proprietary Name | Physiosol |
Generic Name | Sodium Chloride, Sodium Acetate Anhydrous, Sodium Gluconate, Potassium Chloride, And Magnesium Chloride |
Dosage Form | Irrigant |
Route of Administration | IRRIGATION |
Marketing Start Date | 2011-02-11 |
Marketing End Date | 2021-08-01 |
Marketing Category | NDA / NDA |
Application Number | NDA017637 |
Labeler Name | Hospira, Inc. |
Substance Name | SODIUM CHLORIDE; SODIUM ACETATE ANHYDROUS; SODIUM GLUCONATE; POTASSIUM CHLORIDE; MAGNESIUM CHLORIDE |
Active Ingredient Strength | 526 mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL |
Pharm Classes | Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Potassium Compounds [CS],Potassium Salt [EPC],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA],Osmotic Laxative [EPC],Osmotic Activity [MoA],Inhibition Small Intestine Fluid/Electrolyte Absorption [PE],Increased Large Intestinal Motility [PE],Stimulation Large Intestine Fluid/Electrolyte Secretion [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE] |
NDC Exclude Flag | N |
Marketing Start Date | 2011-02-11 |
Marketing End Date | 2021-08-01 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA017637 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2011-02-11 |
Marketing End Date | 2021-08-01 |
Marketing Category | NDA |
Application Number | NDA017637 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2011-02-11 |
Marketing End Date | 2021-08-01 |
Marketing Category | NDA |
Application Number | NDA017637 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2011-02-11 |
Marketing End Date | 2021-08-01 |
Ingredient | Strength |
---|---|
SODIUM CHLORIDE | 526 mg/100mL |
SPL SET ID: | fbae92f4-03ec-4c17-7faf-05c5f7a71af9 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0409-6141 | Physiosol | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, and MAGNESIUM CHLORIDE |
0990-6141 | Physiosol | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, and MAGNESIUM CHLORIDE |
0409-7670 | Normosol-R | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE |
0409-7967 | Normosol-R | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE |
0990-7670 | Normosol-R | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE |
0990-7967 | Normosol-R | SODIUM CHLORIDE, SODIUM ACETATE ANHYDROUS, SODIUM GLUCONATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
PHYSIOSOL 77429321 3495920 Live/Registered |
ICU MEDICAL, INC. 2008-03-24 |
PHYSIOSOL 72449109 0978442 Dead/Expired |
ABBOTT LABORATORIES 1973-02-16 |